跳至主要内容
临床试验/NCT06111599
NCT06111599招募中不适用

Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment

Europainclinics z.ú.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年10月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 3m

研究概览

简要总结

Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment

详细描述

Chronic limb-threatening ischemia (CLTI), the end-stage of lower extremity artery disease (LEAD), occurs with growing prevalence around the globe and is associated with increased healthcare costs. CLTI is defined by the presence of LEAD in combination with rest pain, gangrene, or lower limb ulceration lasting more than two weeks. Despite unclear results of abdominal surgical lumbar sympathectomy, novel interventional minimally invasive fluoroscopy-guided procedures seem to be promising. A prospective interventional study will be conducted, primarily targeting patients afflicted by critical limb ischemia, with the incorporation of thermal vision control and tissue oxygen monitoring.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic limb-threatening ischemia-Patients with chronic leg pain for at least 6 months with intensity (VAS >=5)
  • those who (only if a signature was obtainable), or whose legal guardian,fully understood the clinical trial -details and signed the informed consent form

排除标准

  • Chronic Venous Insufficiency
  • women with positive a pregnancy tests before the trial or who planned to become pregnant within the following 3 years
  • other patients viewed as inappropriate by the staff
  • disagreement with participation in the study

结局指标

主要结局

Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 3m

时间窗: 3 months follow-up

Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 3m measured by VAS 10 point measurement

Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 3m

时间窗: 3 months follow-up

EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression

Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 6m

时间窗: 6 months follow-up

Change From Baseline Visual Analog Pain Scale (VAS) of Back Pain 6m measured by VAS 10 point measurement

Change From Baseline EuroQoL-5 Dimension (EQ-5D) Value 6m

时间窗: 6 months follow-up

EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验